Information for Pharmaceutical and Biotech Industry to actively participate in AFACTT
Creating advanced cellular products and immunomonitoring tools for the personalized treatment of immune-mediated disorders is a team effort. The Management Committee of A FACTT acknowledges that cellular products and accompanying diagnostic tools should be commercialized to enhance their clinical implementation. We therefore invite corporations in the Life Science sector to take active part in this ongoing development.
Are you interested and want to contact us, please fill out our contact form and we will get in touch with you soon.